Search for: "Ortho McNeil Pharmaceutical Inc"
Results 161 - 180
of 184
Sorted by Relevance
|
Sort by Date
4 May 2011, 7:52 am
Brand Name Opioid Products Generic Name Trade Name Applicant/Sponsors Fentanyl Duragesic Extended Release Transdermal System Ortho McNeil Janssen Hydromorphone *Palladone Extended Release Capsules Purdue Pharma Methadone Dolophine Tablets Roxanne Morphine Avinza® Extended Release Capsules King Pharms Morphine Kadian® Extended Release Capsules Actavis Morphine MS Contin Extended Release Tablets … [read post]
25 Jan 2007, 12:48 am
Ortho Pharmaceutical Corp., 661 N.E.2d 352, 355-56 (Ill. 1996). [read post]
28 Jun 2007, 10:16 am
Pfizer, Inc., ___ F. [read post]
2 Mar 2012, 6:52 am
Ortho-McNeil (?) [read post]
9 Aug 2012, 5:00 am
Ortho-McNeil (?) [read post]
15 Jan 2008, 3:06 am
Belnick, Inc. [read post]
4 Mar 2012, 9:02 am
Merrill Dow Pharmaceuticals, Inc., 874 F.2d 307, 311-12 (5th Cir. 1989)(“Fortunately, we do not have to resolve any of the above questions [as to bias and confounding], since the studies presented to us incorporate the possibility of these factors by the use of a confidence interval. [read post]
31 Dec 2015, 5:12 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc., ___ F.3d ___, 2015 WL 8538119 (6th Cir. [read post]
27 Jul 2012, 12:40 pm
Cephalon, Inc., 2010 WL 1257790, at *6 (D.N.J. [read post]
28 Jun 2010, 3:50 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc., No. 2181 (Phila. [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
6 Aug 2009, 11:24 pm
" Ortho-McNeil Pharm., Inc. v. [read post]
28 Oct 2011, 7:00 am
Mylan Pharmaceuticals, Inc., 751 F. [read post]
31 Mar 2010, 1:58 pm
Prods., Inc. v. [read post]
16 May 2013, 2:09 pm
Ortho-McNeil-Janssen Pharmaceuticals, 2013 Phila. [read post]
11 Jul 2008, 4:30 am
, (Daily Dose of IP), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop – Centurion (South Africa): (Afro-IP), 15-16 September: US ACI 10th advanced forum on biotech… [read post]
23 Jun 2014, 12:57 pm
Ortho Pharmaceutical Corp., 788 F. 2d 741, 744–745 (11th Cir. 1986). [read post]
4 Apr 2008, 1:00 am
: (IPBiz) Pharma & Biotech - Products Abilify (Aripiprazole) – Otsuka files US patent infringement suit against Teva over seeking approval for generic Abilify: (IP Law360), Aricept (Donepezil) – US federal judge grants Eisai’s request for preliminary injunction blocking Teva from marketing generic version of Aricept: (IP Law360), (Orange Book Blog), Carbatrol (Carbamazepine) – US federal judge delivers mixed ruling in Shire… [read post]
18 Apr 2008, 2:00 am
Lélos Kai Sia EE (and Others) v GlaxoSmithKline AEVE: (IPKat), US: Bio commends Sen Specter for patent reform stance: (Patent Docs), US: USPTO rules on two of four neural stem cell patents in dispute between StemCells Inc and Neuralstem Inc; parties disagree on how extensively claims amended: (IP Law360), (IPBiz), US: Insmed continues fight for generic biologic approval: (GenericsWeb), Pharma & Biotech - Products Cipralex (Escitalopram)… [read post]
31 May 2007, 4:31 am
Ortho-McNeil Pharmaceutical, Inc., 463 F. [read post]
